Dr. Ronan Glynn:

I do not know that there are weaknesses per se. I would characterise it by stating that there are uncertainties. For example, there are uncertainties around the potential emergence of a variant.

A super spreading event, or a small number of super spreading events, of a variant of concern could alter the picture, as could further issues with vaccine roll-out or the planned roll-out of vaccine in which 80% of the population has its first dose by the end of June. They are the key elements.

I am sure no one believes it but I remain, and have always remained, optimistic about the public's willingness to buy into measures, despite the fatigue. The fact we have not seen an increase in close contacts, per case, since the middle of February is phenomenal. It shows that despite well-publicised incidences in which a small number of people have not complied, the vast majority of people are continuing to try to do the right thing. That, more than anything else, makes me hopeful that we will continue along an appropriate trajectory over the coming weeks and will get to where we need to be by June and into July.